TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New tuberculosis study findings recently were published by researchers at University of Tennessee
July 7th, 2009
In this recent study, researchers in the United States conducted a study "To determine the occurrence of hepatotoxicity associated with rifampin treatment of latent tuberculosis infection in patients from a public health tuberculosis clinic. Evaluation of rifampin hepatotoxicity in adults aged ' 18 years from a database maintained from June 2001 to May 2007 in a public health department clinic." "Rifampin 600 mg daily for 4 months was prescribed. Hepatotoxicity was defined as aspartate aminotransferase (AST) or alanine aminotransferase (ALT) levels more than 3 times the upper limit of normal (ULN) with symptoms or more than 5 times the ULN without symptoms. Rifampin...
Source: TB & Outbreaks Week (2009-07-07)
|
